Navigation Links
Drug companies in India keen on developing bird flu drug

The government is likely to invoke the compulsory licensing (CL) provision in the Patents Act that would enable domestic drug //firms to produce and stockpile Swiss drug maker Roche’s patented drug Tamiflu, useful in combating the global threat against the most dreaded avian flu virus.

Section 92 empowers the government to issue CL without receipt of an application from the industry. Furthermore, the issue of such license is independent of third party consent. The following proposal is expected to help cope up with a public health emergency that might arise in case the pandemic hits India. Once compulsory licensing has been issued, manufacture of the drug can be initiated, to ensure both domestic and international supply.

The drug companies in India are more than willing to participate in the initiative. Ranbaxy Laboratories has already initiated talks with the Swiss pharma company regarding the issue. The company is also getting in touch with governments across the world, interested in sourcing the drug from it.

The situation would however require a critical analysis of patents issue across the world. It would be six months before the drug can actually be manufactured following regulatory approvals.

In response to the above situation, Roche has announced it would not welcome interventions by generic drug makers in Tamiflu market, the demand for which has increased manifold following reports that the pandemic has reached Europe and SE Asia.

Medindia on Bird Flu:

Avian influenza (AI) or Bird Flu is a disease of viral etiology that ranges from a mild or even asymptomatic infection to an acute, fatal disease of chickens, turkeys, guinea fowls, and other avian species, especially migratory waterfowl
'"/>




Page: 1

Related medicine news :

1. India to benefit from pharma companies move
2. Doctors not to accept gifts from drug companies
3. Pharmaceutical companies are targeting patients
4. Historic trial for tuberculosis launched together by leading drug companies
5. Pakistan drug companies seek trade ties with India
6. Depression Accompanies Heart Attacks in Younger Women
7. Cigarette companies adopt devious methods to ensure customer patronage
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. AIDS Disaster in India is Imminent
10. Indian Prime Minister has successful Knee Replacement Surgery
11. International community warns India on HIV situation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... “To Walk ... radioman on a B17 bomber named Edward Koontz. “To Walk Away” is the creation ... Scranton, who has published over two hundred manuscripts in chemistry and religion, as well ...
(Date:8/22/2017)... ... ... “Glimpses Of Light”: is a unique and thought inspiring guide toward self-discovery and ... author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the author has spent most ... “Love is one of the least understood and yet most sought-after pleasures known to ...
(Date:8/22/2017)... ... August 22, 2017 , ... Although Labor Day is ... many communities have begun providing weekend displays, and numerous households celebrate the unofficial end ... can be downright terrifying for pets. , Kris Zambo, owner of Dynamite ...
(Date:8/21/2017)... Los Angeles, California (PRWEB) , ... August 21, ... ... Physicians is announcing the addition of two plastic surgery fellows for academic year ... is designed for candidates who have successfully completed residency in Plastic and Reconstructive ...
(Date:8/21/2017)... Milwaukee, WI (PRWEB) , ... August 21, 2017 ... ... recent years, with events taking place all over the country. , Outdoor running ... that marathon runners are at an increased risk of melanoma, and only half ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
(Date:7/31/2017)... -- 7D Surgical, developer of ground breaking surgical navigation technologies, ... System to support its strategic sales plan in ... Virginia.  7D Surgical has entered into an exclusive sales representative ... facilities within those markets. ... Spartan Medical Purchases 7D ...
(Date:7/27/2017)... July 27, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... ended June 30, 2017.  The Company reported second quarter ... over the prior year period, and an increase of ... basis points of contribution from the LDR Holding Corporation ... second quarter of 2016, or 0.3% on a constant ...
Breaking Medicine Technology: